Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Clinics (Sao Paulo) ; 76: e2882, 2021.
Article in English | MEDLINE | ID: mdl-34190852

ABSTRACT

OBJECTIVES: Antimicrobial stewardship programs (ASPs) comprise coordinated interventions designed to improve antimicrobial use. Understanding the current structure of ASP hospitals will support interventions for the improvement of these programs. This study aimed to describe the status of ASPs in hospitals in São Paulo, Brazil. METHODS: A cross-sectional survey was conducted on the ASPs of hospitals in the state of São Paulo from March to July 2018. Through interviews by telephone or e-mail, we queried which components of the Infectious Diseases Society of America/Society for Healthcare Epidemiology of America and Centers for Disease Control and Prevention guidelines were implemented. RESULTS: The response rate was 30% (28/93 hospitals), and 26 hospitals (85%) reported having a formal ASP. The most frequently implemented strategies were antimicrobial surgical prophylaxis guidelines (100%), empiric sepsis guidelines (93%), and the presence of ASP team members during bedside rounds (96%). The least commonly implemented strategies included prior authorization for all antimicrobials (11%), pharmacokinetic monitoring, and an adjustment program for patients on IV aminoglycosides (3%). Regarding the metrics of the ASP, the most common indicator was the rate of antimicrobial resistance (77%). Eighteen hospitals evaluated antimicrobial consumption using defined daily dose, and only 29% evaluated the days of therapy; 61% of hospitals reported their results to the hospital administration and 39% to the prescribers. CONCLUSIONS: Most hospitals have a formal and active ASP, but with timely actions. We observed inconsistencies between what program leaders understand as the main objective of ASP and the metrics used to evaluate it. Part of the effort for the next few years should be to improve program evaluation metrics and to provide feedback to physicians and hospital leadership.


Subject(s)
Antimicrobial Stewardship , Anti-Bacterial Agents/therapeutic use , Brazil , Cross-Sectional Studies , Hospitals , Humans
2.
Clinics ; 76: e2882, 2021. tab
Article in English | LILACS | ID: biblio-1278929

ABSTRACT

OBJECTIVES: Antimicrobial stewardship programs (ASPs) comprise coordinated interventions designed to improve antimicrobial use. Understanding the current structure of ASP hospitals will support interventions for the improvement of these programs. This study aimed to describe the status of ASPs in hospitals in São Paulo, Brazil. METHODS: A cross-sectional survey was conducted on the ASPs of hospitals in the state of São Paulo from March to July 2018. Through interviews by telephone or e-mail, we queried which components of the Infectious Diseases Society of America/Society for Healthcare Epidemiology of America and Centers for Disease Control and Prevention guidelines were implemented. RESULTS: The response rate was 30% (28/93 hospitals), and 26 hospitals (85%) reported having a formal ASP. The most frequently implemented strategies were antimicrobial surgical prophylaxis guidelines (100%), empiric sepsis guidelines (93%), and the presence of ASP team members during bedside rounds (96%). The least commonly implemented strategies included prior authorization for all antimicrobials (11%), pharmacokinetic monitoring, and an adjustment program for patients on IV aminoglycosides (3%). Regarding the metrics of the ASP, the most common indicator was the rate of antimicrobial resistance (77%). Eighteen hospitals evaluated antimicrobial consumption using defined daily dose, and only 29% evaluated the days of therapy; 61% of hospitals reported their results to the hospital administration and 39% to the prescribers. CONCLUSIONS: Most hospitals have a formal and active ASP, but with timely actions. We observed inconsistencies between what program leaders understand as the main objective of ASP and the metrics used to evaluate it. Part of the effort for the next few years should be to improve program evaluation metrics and to provide feedback to physicians and hospital leadership.


Subject(s)
Humans , Antimicrobial Stewardship , Brazil , Cross-Sectional Studies , Hospitals , Anti-Bacterial Agents/therapeutic use
3.
Cancer ; 122(2): 184-8, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26457577

ABSTRACT

Hyperprolactinemia, defined as a sustained elevation of prolactin (PRL) levels greater than 530 mIU/L in women and greater than 424 mIU/L in men, has been implicated for a long time in breast cancer etiology and prognosis. Elevated PRL values (approximately 2-3 times higher than the reference values) are a common adverse effect of antipsychotic medications, especially with first-generation drugs, and most antipsychotics carry a standard warning regarding PRL elevations on their US product labels. These associations foster undertreatment of serious psychiatric illnesses in both otherwise healthy patients and cancer patients. This review assesses both the preclinical and clinical evidence that has led to the hypothesis of PRL's role in breast cancer risk or breast cancer progression. It is concluded that taken together, the published data are unconvincing and insufficient to deprive cancer patients in general and breast cancer patients specifically of potentially effective antipsychotic or antidepressant medications for serious psychiatric indications. We thus call on revised medication guidelines to avoid the existing undertreatment of serious psychiatric illnesses among cancer patients based on an unproven contraindication to psychiatric medications. Cancer 2016;122:184-188. © 2015 American Cancer Society.


Subject(s)
Antipsychotic Agents/adverse effects , Breast Neoplasms/drug therapy , Hyperprolactinemia/complications , Mental Disorders/drug therapy , Prolactin/blood , Antipsychotic Agents/therapeutic use , Breast Neoplasms/etiology , Breast Neoplasms/physiopathology , Breast Neoplasms, Male/drug therapy , Breast Neoplasms, Male/etiology , Breast Neoplasms, Male/physiopathology , Dose-Response Relationship, Drug , Female , Humans , Hyperprolactinemia/chemically induced , Male , Mental Disorders/diagnosis , Needs Assessment , Prognosis
4.
Lancet Oncol ; 16(14): 1405-38, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26522157

ABSTRACT

Cancer is one of the leading causes of mortality worldwide, and an increasing threat in low-income and middle-income countries. Our findings in the 2013 Commission in The Lancet Oncology showed several discrepancies between the cancer landscape in Latin America and more developed countries. We reported that funding for health care was a small percentage of national gross domestic product and the percentage of health-care funds diverted to cancer care was even lower. Funds, insurance coverage, doctors, health-care workers, resources, and equipment were also very inequitably distributed between and within countries. We reported that a scarcity of cancer registries hampered the design of credible cancer plans, including initiatives for primary prevention. When we were commissioned by The Lancet Oncology to write an update to our report, we were sceptical that we would uncover much change. To our surprise and gratification much progress has been made in this short time. We are pleased to highlight structural reforms in health-care systems, new programmes for disenfranchised populations, expansion of cancer registries and cancer plans, and implementation of policies to improve primary cancer prevention.


Subject(s)
Delivery of Health Care , Insurance, Health/economics , Neoplasms/epidemiology , Caribbean Region , Developed Countries/economics , Humans , Latin America , Neoplasms/economics , Neoplasms/prevention & control
5.
N Engl J Med ; 370(16): 1524-31, 2014 Apr 17.
Article in English | MEDLINE | ID: mdl-24738669

ABSTRACT

We report the case of a patient from Brazil with a bloodstream infection caused by a strain of methicillin-resistant Staphylococcus aureus (MRSA) that was susceptible to vancomycin (designated BR-VSSA) but that acquired the vanA gene cluster during antibiotic therapy and became resistant to vancomycin (designated BR-VRSA). Both strains belong to the sequence type (ST) 8 community-associated genetic lineage that carries the staphylococcal chromosomal cassette mec (SCCmec) type IVa and the S. aureus protein A gene (spa) type t292 and are phylogenetically related to MRSA lineage USA300. A conjugative plasmid of 55,706 bp (pBRZ01) carrying the vanA cluster was identified and readily transferred to other staphylococci. The pBRZ01 plasmid harbors DNA sequences that are typical of the plasmid-associated replication genes rep24 or rep21 described in community-associated MRSA strains from Australia (pWBG745). The presence and dissemination of community-associated MRSA containing vanA could become a serious public health concern.


Subject(s)
Bacteremia/microbiology , Methicillin-Resistant Staphylococcus aureus/genetics , Vancomycin Resistance/genetics , Adult , Brazil , Gene Transfer, Horizontal , Genome, Bacterial , Humans , Male , Microbial Sensitivity Tests , Multigene Family , Mycosis Fungoides/complications , Plasmids/genetics , Sequence Analysis, DNA
6.
Fisioter. mov ; 17(4): 65-72, out.-dez. 2004. tab, graf
Article in Portuguese | LILACS | ID: lil-405297

ABSTRACT

Trarta-se de um ensaio clínico randomizado, com o objetivo de analisar qual das frequências da corrente interferencial vetorial adotadas na pesquisa promoveria dimunui;cão significativa da sensibilidade dolorosa nos tender points dos músculos trapézios em pacientes xcom diagnóstico de fibromilagia. Foram selecionados onze indivíduos do sexo feminino, atendidos em 10 sessões, com frequência de duas vezes por semana, e distribuídos, aleatoriamente, em dois grupos com diferentes frequ6encias da corrente interferencial: 20 e 150 Hz. A análise comparativa foi realizada de acordo com a Escala Visual Analógica de dor e pressão digital exercida nos pontos dolorosos, antes e após as aplicações. Obteve-se um resultado significativo no que diz respeito à analgesia e melhora da qualidade de vida promovida pela frequência de 20 Hz em comparação com a de 150 Hz, enquanto que os dois grupos apresentaram diferença significativa em relação à pressão digital exercida no local da dor. Novas investigações, com amior número de casos e acompanhadas por maior período de tempo, com a utilização do dolorímetro para avaliação mais fidedigna da dor, devem ser realizadas


Subject(s)
Humans , Female , Adult , Aged , Fibromyalgia/diagnosis , Fibromyalgia/therapy , Signs and Symptoms , Pain , Quality of Life
SELECTION OF CITATIONS
SEARCH DETAIL
...